Nasal spray gel for chronic sinusitis with staph infection
Treatments studied
Part of Infections clinical trials.
This trial tests a special nasal spray gel that combines stem cell exosomes, an antibiotic, and an enzyme to treat chronic sinusitis caused by staph bacteria. It aims to reduce infection and improve symptoms like nasal blockage and discharge.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have had chronic sinusitis (without nasal polyps) for more than 12 weeks.
- A nasal exam shows pus-like discharge, and a culture confirms staph bacteria.
- Your sinus symptoms score is at least 30 on a standard questionnaire.
- You have not had sinus surgery in the last 6 months, and you are not allergic to the spray ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if transplanting healthy nasal bacteria from a donor can help people with chronic sinusitis. It aims to restore a healthy microbiome in the nose to reduce symptoms like congestion and discharge.
This study tests a new medication called CM326 for people with long-term sinus inflammation and nasal polyps. The goal is to see if it reduces symptoms like congestion and improves quality of life. You will receive either the study drug or a placebo.
This study tests whether combining mepolizumab (a biologic injection) with a quick in-office removal of nasal polyps improves symptoms better than usual care. It is for adults with chronic sinusitis and nasal polyps who qualify for biologic therapy.
This trial tests a new nasal spray that combines exosomes (tiny cell messengers), azelastine (an antihistamine), and interferon (a protein that helps fight infections) for people with chronic sinusitis. It aims to reduce symptoms and improve your sinus condition.
This study tests a nasal spray made from mastic oil combined with a lower dose of a standard steroid medication (mometasone) for people with chronic sinusitis. It aims to see if this combination is effective in reducing symptoms.
This study tests a new sinus stent that slowly releases medication to treat chronic sinusitis. It may reduce symptoms and help avoid repeated surgeries.
Hear when a new Chronic Rhinosinusitis With Nasal Polyps trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.